$Scinai Immunotherapeutics(SCNI.US)$Scinai Immunotherapeutics Advances NanoAb Pipeline Scinai Immunotherapeutics Ltd. Sponsored Adr (SCNI) has released an update. Scinai Immunotherapeutics Ltd. is gaining traction with the development of its nanosized antibodies (NanoAbs), which promise significant clinical and commercial advantages over traditional human monoclonal antibodies. The company has highlighted the potential for NanoAbs in the treatment and prevention of diseases like psoriasis...
$Scinai Immunotherapeutics(SCNI.US)$Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and CGMP Manufacturing Services. Min 1.8 million in rev over next 5 years! PR Newswire· 2 mins ago
$Scinai Immunotherapeutics(SCNI.US)$Scinai Immunotherapeutics Regains Compliance with Nasdaq's Stockholders' Equity Rule 3 MINUTES AGO, 7:30 AM EST VIA PR NEWSWIRE
$Scinai Immunotherapeutics(SCNI.US)$So the company believes they made the adjustments to comply with the minimum shareholder equity? Now lets see if nasdaq sees it the same and issues a compliance letter?
Scinai Immunotherapeutics股票讨论区
Scinai Immunotherapeutics Ltd. Sponsored Adr (SCNI) has released an update.
Scinai Immunotherapeutics Ltd. is gaining traction with the development of its nanosized antibodies (NanoAbs), which promise significant clinical and commercial advantages over traditional human monoclonal antibodies. The company has highlighted the potential for NanoAbs in the treatment and prevention of diseases like psoriasis...
PR Newswire· 2 mins ago
3 MINUTES AGO, 7:30 AM EST
VIA PR NEWSWIRE
暂无评论